These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Platelet inhibitor therapy. Agents and clinical implications. Webster MW; Chesebro JH; Fuster V Hematol Oncol Clin North Am; 1990 Feb; 4(1):265-89. PubMed ID: 2179212 [TBL] [Abstract][Full Text] [Related]
6. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina. Machado AP; Saavedra JA; Ribeiro C Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224 [TBL] [Abstract][Full Text] [Related]
7. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736 [TBL] [Abstract][Full Text] [Related]
8. The endothelium and control of blood vessel function in health and disease. Schiffrin EL Clin Invest Med; 1994 Dec; 17(6):602-20. PubMed ID: 7895424 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors]. Tschudi MR; Noll G; Lüscher TP Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890 [TBL] [Abstract][Full Text] [Related]
10. Effects of garlic on platelet biochemistry and physiology. Rahman K Mol Nutr Food Res; 2007 Nov; 51(11):1335-44. PubMed ID: 17966136 [TBL] [Abstract][Full Text] [Related]
11. [Nitric oxide: the endogenous nitrate in the cardiovascular system]. Tschudi MR; Lüscher TF Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925 [TBL] [Abstract][Full Text] [Related]
12. [Hypertension and vascular diseases: molecular and cellular mechanisms]. Lüscher TF Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405 [TBL] [Abstract][Full Text] [Related]
13. Endothelium dysfunction in the coronary circulation. Lüscher TF; Noll G J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060 [TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy. Christie DJ; Kottke-Marchant K; Gorman RT Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773 [TBL] [Abstract][Full Text] [Related]
15. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo. Buerkle MA; Lehrer S; Sohn HY; Conzen P; Pohl U; Krötz F Circulation; 2004 Oct; 110(14):2053-9. PubMed ID: 15451781 [TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152 [TBL] [Abstract][Full Text] [Related]
18. [Role of endothelial nitric oxide in the regulation of the vasomotor system]. Michel JB Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914 [TBL] [Abstract][Full Text] [Related]
19. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes. Mikhail N; Fukuda N; Tremblay J; Hamet P J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of platelet activation-inhibitory drugs. Rao GH; Rao AT Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]